Literature DB >> 32238585

Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy.

Danilo Licastro1, Sreejith Rajasekharan2, Simeone Dal Monego1, Ludovica Segat3, Pierlanfranco D'Agaro4, Alessandro Marcello5.   

Abstract

Entities:  

Keywords:  COVID-19; Italy; SARS-CoV-2

Mesh:

Substances:

Year:  2020        PMID: 32238585      PMCID: PMC7269454          DOI: 10.1128/JVI.00543-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


× No keyword cloud information.

LETTER

In December 2019, the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the city of Wuhan in Hubei province, People’s Republic of China, as the etiologic agent of coronavirus disease 2019 (COVID-19), which has hence spread worldwide causing a global pandemic (1–3). The epidemic has been growing exponentially in Italy for the last month, affecting over 60,000 individuals so far and with a heavy mortality burden. Italy is only anticipating what will be the trend in the whole of Europe and elsewhere. At the beginning of March 2020, the first nasopharyngeal swabs positive for SARS-CoV-2 started to be detected in the Northern Eastern Region of Friuli-Venezia Giulia. These identifications followed the expansion of the two clusters in Lombardy and Veneto that emerged in the previous weeks in northern Italy (4). Swab contents were seeded on Vero E6 cells and monitored for cytopathic effect and by an RT-PCR protocol using primers for the N region (5). Cell culture supernatants from passage 1 (P1) of four isolates were collected, and RNA was extracted with QIAamp viral RNA minikit (Qiagen) and quantified with an in vitro-transcribed RNA standard (S. Rajasekharan and A. Marcello, unpublished data). The quantity and quality of the RNA were assessed using Qubit 2.0 fluorometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer (Agilent Technologies). For each sample, 100 ng of total RNA was processed using Zymo-Seq RiboFree ribosomal depletion library preparation kit (Zymo Research). All the obtained libraries passed quality check and were quantified before being pooled at equimolar concentration and sequenced on Illumina Nano MiSeq 2- by 150-bp paired-end mode following standard procedures. Sequenced reads that passed the quality check (Phred score ≥30) were adaptor and quality trimmed, and the remaining reads were assembled de novo using Megahit (v.1.2.9) with default parameter settings. Megahit generated in all cases 7 contigs with more than 1,000 bp and 100× coverage; all of these assembled contigs were compared (using BLASTn) against the entire nonredundant (nr) nucleotide and protein databases. In all cases the longest and more covered contigs were identified as MT019532.1, “Severe acute respiratory syndrome coronavirus 2 isolate BetaCoV/Wuhan/IPBCAMS-WH-04/2019, complete genome,” with 99% identity and 0 gaps. The longer sequences were named hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9 and were deposited in GISAID (see below). Sequence analysis showed an uneven coverage along the SARS-CoV-2 genome, with an average range from 126 to 7,576 reads and a mean coverage per sample of 1,169× (Fig. 1). Phylogenetic trees were inferred using the maximum likelihood method implemented in the MEGAX program using the GISAID sequences available at 03-16-2020 (6). Bootstrap support values were calculated from 500 pseudoreplicate trees of the whole data set (Fig. 2).
FIG 1

Sample coverage tracks from UCSC browser on ASM985889v3/SARS-CoV-2 assembly. Loaded tracks include UniProt Proteins track, RefSeq Acc track, and sample coverage tracks obtained after mapping raw reads to ASM985889v3 and converted using BEDTools genomecov function. Highlighted position refers to D614G variation in S protein revealed in all sequenced cases.

FIG 2

Maximum likelihood phylogenetic trees of nucleotide sequences from GISAID sequences available at 03-16-2020 and hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9. A portion of the G clade based on S variation D614G is shown with indication of the phylogenetic tree branches including reporting cases (purple) and the other two deposited Lombardy sequences (red dot).

Sample coverage tracks from UCSC browser on ASM985889v3/SARS-CoV-2 assembly. Loaded tracks include UniProt Proteins track, RefSeq Acc track, and sample coverage tracks obtained after mapping raw reads to ASM985889v3 and converted using BEDTools genomecov function. Highlighted position refers to D614G variation in S protein revealed in all sequenced cases. Maximum likelihood phylogenetic trees of nucleotide sequences from GISAID sequences available at 03-16-2020 and hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9. A portion of the G clade based on S variation D614G is shown with indication of the phylogenetic tree branches including reporting cases (purple) and the other two deposited Lombardy sequences (red dot). Despite a high burden of COVID-19 in Italy, very little information is available to date from full-length high-quality sequences. The first sequences deposited in GISAID (EPI_ISL_410545 and EPI_ISL_410546) were collected in Rome from a Chinese tourist from Hubei province who got infected before visiting Italy, and another one (EPI_ISL_412974) was from a test-positive Italian citizen returning from China. Only two sequences were reported from the Lombardy cluster (EPI_ISL_412973 and EPI_ISL_413489). In this report four additional sequences from cases epidemiologically linked to northern Italy have been examined. All infected individuals were connected to the city of Udine; S1 and S5 were from the same cluster of closely related cases, while S9 got infected probably in Lombardy and S8 visited Udine from a neighboring city (Table 1). Sequence analysis showed a good coverage along the SARS-CoV-2 genome for all four isolates (Fig. 1). Based on the marker variant S D614G, all four sequences grouped in the Bavarian rooted subclade G, which is dominant in Europe, including the sequence from Lombardy, but distinct from the three sequences mentioned above originating directly from China (7). Intriguingly, the new isolates were more closely related to EPI_ISL_412973, while EPI_ISL_413489 was more distant (Fig. 2). No evidence could be found for the putative 382-nucleotide (nt) deletion in ORF8 detected in Singapore, which has been proposed to indicate an attenuated phenotype (8).
TABLE 1

Data for infected individuals

Sequence no.Age (yr)SexResidenceCluster
159FUdineMeeting in Udine
573MUdineMeeting in Udine
845MGoriziaVisit to Udine
959MUdineVisit to Milan
Data for infected individuals These findings strongly urge the need for comprehensive studies that combine genomic data with epidemiological data and clinical records of symptoms from patients with COVID-19.

Data availability.

The longer sequences were named hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9 and were deposited in GISAID (https://www.gisaid.org/) with accession numbers EPI_ISL_417418, EPI_ISL_417419, EPI_ISL_417421, and EPI_ISL_417423, respectively (9).
  6 in total

1.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

2.  GISAID: Global initiative on sharing all influenza data - from vision to reality.

Authors:  Yuelong Shu; John McCauley
Journal:  Euro Surveill       Date:  2017-03-30

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  The first two cases of 2019-nCoV in Italy: Where they come from?

Authors:  Marta Giovanetti; Domenico Benvenuto; Silvia Angeletti; Massimo Ciccozzi
Journal:  J Med Virol       Date:  2020-02-12       Impact factor: 2.327

5.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

6.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Authors:  Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten
Journal:  Euro Surveill       Date:  2020-01
  6 in total
  23 in total

1.  Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2.

Authors:  Sreejith Rajasekharan; Rafaela Milan Bonotto; Lais Nascimento Alves; Yvette Kazungu; Monica Poggianella; Pamela Martinez-Orellana; Natasa Skoko; Sulena Polez; Alessandro Marcello
Journal:  Viruses       Date:  2021-04-30       Impact factor: 5.048

Review 2.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

3.  Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.

Authors:  Komi Nambou; Manawa Anakpa
Journal:  Infect Genet Evol       Date:  2020-07-22       Impact factor: 3.342

Review 4.  Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery.

Authors:  P Chellapandi; S Saranya
Journal:  Med Chem Res       Date:  2020-07-31       Impact factor: 2.351

5.  Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.

Authors:  Paul D Hartley; Richard L Tillett; David P AuCoin; Joel R Sevinsky; Yanji Xu; Andrew Gorzalski; Mark Pandori; Erin Buttery; Holly Hansen; Michael A Picker; Cyprian C Rossetto; Subhash C Verma
Journal:  J Genet Genomics       Date:  2021-02-18       Impact factor: 4.275

6.  SARS-CoV-2 genome sequencing from post-mortem formalin-fixed, paraffin-embedded lung tissues.

Authors:  Claude Van Campenhout; Ricardo De Mendonça; Barbara Alexiou; Sarah De Clercq; Marie-Lucie Racu; Claire Royer-Chardon; Stefan Rusu; Marie Van Eycken; Maria Artesi; Keith Durkin; Patrick Mardulyn; Vincent Bours; Christine Decaestecker; Myriam Remmelink; Isabelle Salmon; Nicky D'Haene
Journal:  J Mol Diagn       Date:  2021-06-18       Impact factor: 5.568

Review 7.  Pathophysiology and treatment strategies for COVID-19.

Authors:  Manoj Kumar; Souhaila Al Khodor
Journal:  J Transl Med       Date:  2020-09-15       Impact factor: 5.531

8.  Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing.

Authors:  Federica Alessandrini; Sara Caucci; Valerio Onofri; Filomena Melchionda; Adriano Tagliabracci; Patrizia Bagnarelli; Laura Di Sante; Chiara Turchi; Stefano Menzo
Journal:  Genes (Basel)       Date:  2020-08-12       Impact factor: 4.096

9.  Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic.

Authors:  Wenjuan Zhang; John Paul Govindavari; Brian D Davis; Stephanie S Chen; Jong Taek Kim; Jianbo Song; Jean Lopategui; Jasmine T Plummer; Eric Vail
Journal:  JAMA Netw Open       Date:  2020-10-01

10.  Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.

Authors:  Ting Zheng; Chao Yang; Han-Yu Wang; Xiao Chen; Li Yu; Zi-Ling Wu; Hui Sun
Journal:  J Med Virol       Date:  2020-07-14       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.